Fagron Compounding Services Recall: bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 m
Fagron Compounding Services Recall: bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 m is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Fagron Compounding Services; Product: bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Se
| Recalling firm | Fagron Compounding Services |
|---|---|
| Product | bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226 |
| Reason for recall | Lack of Assurance of Sterility |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Ongoing |
| Distribution | USA nationwide. |
| Recall initiated | 20250829 |
| Recall number | D-0646-2025 |
| Category | drug |
| State | KS |
| Country | United States |
$29/mo
Try RecallGuard →